Acute kidney injury (AKI) is associated with mortality and may lead to increased medical expense. A modified criteria (pediatric RIFLE [pRIFLE]: Risk, Injury, Failure, Loss, and End-stage renal disease) has been proposed to standardize the definition of AKI. The common causes of AKI are renal ischemia, nephrotoxic medications, and sepsis. A majority of critically ill children develop AKI by the pRIFLE criteria and need to receive intensive care early in the course of AKI. Factors influencing patient survival (pediatric intensive care unit discharge) are known to be low blood pressure at the onset of renal replacement therapy (RRT), the use of vasoactive pressors during RRT, and the degrees of fluid overload at the initiation of RRT. Early intervention of continuous RRT (CRRT) has been introduced to reduce mortality and fluid overload that affects poor prognosis in patients with AKI. Here, we briefly review the practical prescription of pediatric CRRT and literatures on the outcomes of patients with AKI receiving CRRT and associations among AKI, fluid overload, and CRRT. In conclusion, we suggest that an increased emphasis should be placed on the early initiation of CRRT and fluid overload in the management of pediatric AKI.
Mauro Neri, Gianluca Villa, Francesco Garzotto, Sean M. Bagshaw, Rinaldo Bellomo, Jorge Cerdá, Fiorenza Ferrari, Silvia Guggia, Michael Joannidis, John A. Kellum, Jeong Chul Kim, Ravindra L. Mehta, Zaccaria Ricci, Alberto Trevisani, Silvio Marafon, William R. Clark, Jean Louis Vincent, Claudio Ronco
Alejandra Molano‐Triviño, Eduardo Zúñiga, Juan Camilo Castellanos De la Hoz, José García-Habeych, Sandra Saumett, Carlos M. Duarte, Andrés Salgado-Vasco, Danilo E. Trujillo González, Carlos F. Suárez, Marielys E. Quiñones Pérez
Claudio Ronco, Zaccaria Ricci, Daniel De Backer, John A. Kellum, Fabio Silvio Taccone, Michael Joannidis, Peter Pickkers, Vincenzo Cantaluppi, Franco Turani, Patrick Saudan, Rinaldo Bellomo, Olivier Joannès-Boyau, Massimo Antonelli, Didier Payen, John R. Prowle, Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.